Anaconda Biomed SL
Latest round
- Series A
Last raised
- May 2017
Total raised
- $17M
Investors
- 4
About Anaconda Biomed SL
Anaconda Biomed SL develops advanced medical devices, focusing on innovative catheter systems for mechanical thrombectomies, addressing critical needs in stroke treatment with its specialized products. Founded in 2015 in Barcelona, Spain, Anaconda Biomed SL specializes in advanced catheter systems for thrombectomy procedures. The company was co-founded by Inyaki Galve and Ofir Arad, who possess relevant experience in the medical device industry.L. specializes in innovative medical devices, primarily focusing on advanced catheter systems designed for performing mechanical thrombectomies. The company's flagship offerings, the ANA and ANA5 systems, consist of coaxial catheters that facilitate the safe and efficient removal of blood clots from neurovascular vessels. These devices have been engineered to support clot attachment to retrieval devices, thereby reducing the risks associated with clot detachment and increasing the efficacy of thrombectomy procedures. The products are intended for use in critical medical situations, specifically for patients experiencing acute ischemic strokes resulting from large vessel neurovascular occlusions. Anaconda Biomed serves healthcare professionals and hospitals across various markets, including Europe and North America, in need of reliable solutions for stroke treatment. Anaconda Biomed operates on a revenue model centered around the sale of its advanced catheter systems to hospitals and medical facilities, which utilize these devices for interventional procedures in acute ischemic stroke cases. The business transactions typically involve direct sales to healthcare providers, where the devices are offered as single-use, sterile products that are essential for thrombectomy interventions. Each of the company's products is positioned to address specific clinical needs, with pricing structured around the complexity and technology behind the devices.40.
Who invested in Anaconda Biomed SL
4 investors across 2 rounds
See all investors in Anaconda Biomed SL
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Anaconda Biomed SL
Who invested in Anaconda Biomed SL?
Anaconda Biomed SL has 4 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Anaconda Biomed SL raised?
Anaconda Biomed SL has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Anaconda Biomed SL last raise money?
Anaconda Biomed SL's most recent round on record is a Series A, in May 2017.
What does Anaconda Biomed SL do?
Anaconda Biomed SL develops advanced medical devices, focusing on innovative catheter systems for mechanical thrombectomies, addressing critical needs in stroke treatment with its specialized products.
Where is Anaconda Biomed SL headquartered?
Anaconda Biomed SL is headquartered in Barcelona, Spain.
Which VCs invest in companies like Anaconda Biomed SL?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Highland Europe back medical devices & equipment companies at Anaconda Biomed SL's stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Series A
Raising like Anaconda Biomed SL? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.